Loading company details...
Beta
Latest Form 4 (Feb 24, 2025): Clay Thorp (Director): Purchase of 15,000 shares, $13.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 24, 2025 | Clay Thorp | Purchase | 15,000 | $13.8K |
| Jan 10, 2025 | Charles A. Deignan, Chief Financial Officer | Grant/Award | 200,000 | n/a |
| Jan 10, 2025 | Ngai Hang Victor Chong, Chief Medical Officer | Grant/Award | 250,000 | n/a |
| Jan 10, 2025 | George M. Lasezkay, CEO | Grant/Award | 500,000 | n/a |
| Nov 4, 2024 | Ngai Hang Victor Chong, Chief Medical Officer | Purchase | 36,500 | $36.5K |
| Jun 24, 2024 | Ngai Hang Victor Chong, Chief Medical Officer | Purchase | 23,500 | $24.9K |
| Jun 21, 2024 | Anthony S. Gibney | Grant/Award | 45,000 | n/a |
| Jun 21, 2024 | Benjamin R. Yerxa | Grant/Award | 45,000 | n/a |
| Jun 21, 2024 | Nancy J. Hutson | Grant/Award | 45,000 | n/a |
| Jun 21, 2024 | Richard Croarkin | Grant/Award | 45,000 | n/a |